• LAST PRICE
    2.4600
  • TODAY'S CHANGE (%)
    Trending Down-0.1900 (-7.1698%)
  • Bid / Lots
    2.4900/ 8
  • Ask / Lots
    2.5000/ 2
  • Open / Previous Close
    2.6900 / 2.6500
  • Day Range
    Low 2.4350
    High 2.7400
  • 52 Week Range
    Low 1.2500
    High 2.9300
  • Volume
    10,333,067
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • May 9, 2024

      Show headlines and story abstract
    • 6:13AM ET on Thursday May 09, 2024 by MT Newswires
      Companies Mentioned: SNDL
      06:13 AM EDT, 05/09/2024 (MT Newswires) -- ...
    • 6:01AM ET on Thursday May 09, 2024 by PR Newswire
      Companies Mentioned: SNDL

      The Company reports increased revenue year-over-year and record profit margin

      SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the first quarter ended March 31, 2024. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated.

    • 6:01AM ET on Thursday May 09, 2024 by Dow Jones
      Companies Mentioned: SNDL
    • 6:00AM ET on Thursday May 09, 2024 by CNW Group
      Companies Mentioned: SNDL

      COMTEX_452109474/2669/2024-05-09T06:00:58

    • 6:00AM ET on Thursday May 09, 2024 by Dow Jones
      Companies Mentioned: SNDL

      (Unaudited --expressed in thousands of Canadian dollars)
      Three months endedMarch 31 2024 2023 Cash provided by (used in): Operating activities Net loss for the period (4,652) (36,143) Adjustments for: Income tax recovery (2,997) -- Interest and fee income (4,091) (4,211) Change in fair value of biological assets (232) 3,535 Share-based compensation 4,843 2,209 Depreciation and amortization 14,570 18,259 Loss on disposition of assets 78 184 Inventory impairment and obsolescence 1,913 9,177 Finance costs, net 1,625 5,173 Change in estimate of fair value of derivative warrants 1,300 (4,802) Unrealized foreign exchange loss 104 48 Transaction costs 164 -- Asset impairment 1,656 807 Share of (profit) of equity-accounted investees (9,148) (9,516) Realized loss on settlement of marketable securities -- 43,804 Unrealized (gain) loss on marketable securities 55 (38,635) Proceeds from settlement of marketable securities -- 26 Interest received 3,172 3,703 Change in non-cash working capital (5,059) (42,562) Net cash used in operating activities from continuing operations 3,301 (48,944) Net cash provided by operating activities from discontinued operations -- 147 Net cash used in operating activities 3,301 (48,797) Investing activities Additions to property, plant and equipment (2,410) (1,394) Additions to intangible assets -- (17) Changes to investments 133 (827) Changes to equity-accounted investees 168 (7,546) Proceeds from disposal of property, plant and equipment (62) 82 Acquisitions, net of cash acquired -- 3,695 Change in non-cash working capital 495 (459) Net cash used in investing activities from continuing operations (1,676) (6,466) Net cash used in investing -- -- activities from discontinued operations Net cash used in investing activities (1,676) (6,466) Financing activities Change in restricted cash (231) (42) Payments on lease liabilities, net (7,516) (9,491) Repurchase of common shares, net of costs -- (1,536) Change in non-cash working capital 35 (1) Net cash used in financing activities from continuing operations (7,712) (11,070) Net cash used in financing -- -- activities from discontinued operations Net cash used in financing activities (7,712) (11,070) Effect of exchange rate changes on -- -- cash held in foreign currency Change in cash and cash equivalents (6,087) (66,333) Cash and cash equivalents, beginning of period 195,041 279,586 Cash and cash equivalents, end of period 188,954 213,253

Peers Headlines